Since its inception, Digipath Labs has collected data on every strain of cannabis it has studied and tested. The result is a living, growing, and well-defined understanding of the science of cannabis and its practical application in all phases of product development. With leading cannabis scientist Dr. Cindy Orser officiating the Company’s technology, Digipath is now prepared to provide to aspiring cannabis product producers the “Science to Succeed” through the GroSciences Subsidiary.
“GroSciences provides the much-needed formulations and recipes to pursue real-world success. Our formulations are science-backed creations derived from years of testing cannabis and cannabis-based products at one of the most respected labs in the world, said Dr. Orser, Chief Science Officer, Digipath, Inc. And they will soon be available for private-label producers. GroSciences provides both the footprints in the minefield and the runway to cannabis opportunity.”.
Dr. Cindy Orser, Ph.D., a 20-year biotech and diagnostic industry veteran, leads these efforts on behalf of Digipath, serving as Chief Science Officer and assists cannabis providers and regulatory agencies, as well as working in academia in several key roles. In addition to her work, she holds 18 patents and authored 41 peer-reviewed publications.
Our formulations are science-backed creations derived from years of testing cannabis and cannabis-based products at one of the most respected labs in the world. They will soon be available for private-label producers. GroSciences provides both the footprints in the minefield and the runway to cannabis opportunity.
Hops used in the production of beer contains terpenes, a group of bioactive compounds made by all plants and mammals. Currently there is little control in the resulting terpene footprint left behind after the brewing process. GroSciences has developed a method for mimicking cannabis terpene chemoprofiles and/or creating physiologically impactful terpene chemoprofiles in finished beer and other beverages allowing for the creation of functionalized beverages with no cannabinoids for the mass market.
Fungal infections reduce cannabis yield by around 15%, which can be a significant revenue loss. The use of synthetic fungicides present their own regulatory, economic and public health risks. GroSciences has developed a method for selecting and developing all-natural, plant-derived pesticide control agents for cannabis and hemp based on terpenes, a group of bioactive compounds made by all plants and mammals. These products have application to crops other than in the cannabis industry.
GroSciences has developed a simple molecular assay, Tru-Hemp ID, that can distinguish industrial hemp from drug-type CBD and drug-type THC under two hours in a portable format that works on plant material of any age